Supporting ECPC’s work related to research projects and other activities involving the creation and dissemination of scientific information.
Ulrik Ringborg completed his doctoral thesis at the Karolinska Institute (Sweden) in 1971 and was appointed as Associate Professor the same year. He became Associate Professor of General Oncology in 1978, qualifying as an oncology specialist in 1979. In 1992, he was made Senior Consultant at the Department of General Oncology, Radiumhemmet, Professor of Oncology at the Karolinska Institute, and Head of the Department of Oncology, Karolinska Hospital. From 1993, he was Prefect at the Institute of Oncology-Pathology and continued his long-running service with Karolinska Hospital heading their Oncologic Clinic, becoming a member of the Executive Group, and now Senior Physician, Professor of Oncology, and Director of the Cancer Center Karolinska. He has served as a member on countless boards and assemblies including the King Gustaf V Jubilee Fund, the Nobel Assembly and the Swedish Cancer Society. Ulrik Rinborg was also a member of the Scientific Advisory Committee of EORTC and Member of Policy Committee of ECCO – the European CanCer Organisation. Since since 2009, Ulrik is Secretary General of the European Academy of Cancer Sciences.
“After a research education in cell and molecular biology cancer was an attractive clinical discipline, representing one of the main healthcare problems. Soon I experienced the gap between the innovative basic/preclinical research at the Karolinska Institutet and the clinical research at the Karolinska Hospital and I wanted to focus on structuring translational cancer medicine. I participated in the establishment of the Cancer Center Karolinska, our translational cancer research structure since more than 20 years, and in the work within the Organisation of European Cancer Centres (OECI) to quality assure cancer care/research environments in terms of Comprehensive Cancer Centres. To be able to balance the increasing cancer problem we need development of Personalized/Precision Cancer Medicine based on international research collaborations and improved infrastructure support. To innovate for patients research is needed for all components of the entire cancer care continuum. European Academy of Sciences is now the organisation with this focus and with the aim to join the European cancer organisations to a common vision and strategy. The ongoing work in cancer will most probably be a model for the other main chronic diseases in the future.“
We understand that when you make a donation, you want to know exactly what happens to your money. We aim to be clear and transparent when it comes to using your contributions in our mission to fight cancer.Your donations not only help us to empower the cancer patient community and make a positive difference to healthcare, treatment and accessibility, but also enable us to:
ensure our members are engaged and feel part of an active community through information, training, unique resources, tools, opportunities and networking at a national and European level
legitimise our position of cancer patient representatives before decision-makers
build a reputation as a cancer patient expert within the scientific community
find partners sharing the same vision, values and goals to work together on projects
get the media’s attention in order to publish and disseminate our messages